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A complete cDNA clone of the genome (15,246 nucleotides) of the paramyxovirus SV5 was constructed from cDNAs
such that an anti-genome RNA could be transcribed by T7 RNA polymerase and the correct 3* end generated by cleavage
using hepatitis delta virus ribozyme. The plasmid encoding the antigenome sequence was transfected into cells previously
infected with recombinant vaccinia virus that expressed T7 RNA polymerase, together with helper plasmids that expressed
the viral replication proteins, NP, P, and L, under the control of the T7 polymerase promoter. Rescue of the RNA genome
from DNA was demonstrated by recovering SV5 with the tag restriction sites introduced into the DNA clone, using RT-PCR
of the genome RNA and nucleotide sequencing. Rescue of SV5 from DNA did not require expression of the viral V protein
as a helper plasmid, suggesting that V protein is not essential for initial replication. The infectious cDNA of SV5 was also
manipulated to express green fluorescent protein (GFP) under the control of SV5 transcriptional start and stop signals
introduced between the HN and L genes. The amount of GFP that was expressed varied depending on the nature of the
newly introduced transcription signals. q 1997 Academic Press
INTRODUCTION For RNA viruses with infectious nucleic acid genomes
(positive strand viruses), the development of the abilitySimian virus 5 (SV5) was independently isolated in
to recover infectious virus from cloned DNA, first with1956 and 1964 from monkey kidney cell culture (Choppin,
bacteriophage Qb (Taniguchi et al., 1978) and then with1964; Hull et al., 1956) and it is very closely related to
polio virus (Racaniello and Baltimore, 1981), and subse-canine parainfluenza virus. These viruses are members
quently with many positive strand RNA viruses, permittedof the Rubulavirus genus of the family Paramyxovirus.
the ability to perform reverse genetics; i.e., the introduc-Other members of the genus include mumps virus, hu-
tion of site-specific mutations into the viral genomes. Forman parainfluenza virus type 1 and type 4, and Newcastle
the negative-stranded RNA viruses, where the minimaldisease virus. Members of the genus Paramyxovirus of
unit of infectivity is the RNA encapsidated with the nu-the family Paramyxovirus include Sendai virus, human
cleocapsid protein and associated RNA-dependent RNAparainfluenza virus type 3, and genus Morbillivirus of
polymerase activity, the requirements for a genetic sys-the family Paramyxovirus includes measles virus, canine
tem are more complex as a functional nucleocapsid hasdistemper virus, and rinderpest virus. SV5 has the distinc-
to be assembled.tion among the subfamily Paramyxovirinae of containing
the smallest RNA genome (15,246 nucleotides). SV5 en- For influenza virus with its eight segments of negative-
codes (3* to 5* on genome RNA) the nucleocapsid protein stranded RNA, the ability to reconstitute the enzymati-
(NP), the V protein (V), and P phosphoprotein (P), the cally active nucleocapsid on synthetic RNA segments,
matrix protein (M), the fusion protein (F), the small hy- coupled with strong selection schemes, has made it pos-
drophobic integral membrane protein (SH), the hemag- sible to rescue influenza viruses (Enami et al., 1990; Luyt-
glutinin-neuraminidase (HN), and the polymerase protein jes et al., 1989; reviewed in Palese et al., 1996). This
(L). The NP, P, V, and L proteins are associated with the technology has proven useful for examining aspects of
nucleocapsid core, the M protein is a peripheral mem- the replication of the virus and for examining structure/
brane protein, and the SH, F, and HN proteins are integral function relationships of the glycoproteins, hemaggluti-
membrane proteins, the latter two are involved in virus nin, and neuraminidase (e.g., references, Garcia-Sastre
attachment and viral entry into cells (reviewed in Lamb and Palese, 1995; Jin et al., 1994; 1996; 1997; Mitnaul et
and Kolakofsky, 1996). al., 1996).
For the nonsegmented negative-strand RNA viruses,
1 Present address: Oakton College, Des Plaines, IL. attempts to manipulate the entire genome were facili-
2 To whom correspondence and reprint requests should be ad- tated by studies using short genomes (cloned defectivedressed at Department of Biochemistry, Molecular Biology and Cell
interfering particles or artificial minireplicons), whichBiology, Northwestern University, 2153 North Campus Drive, Evanston,
IL 60208-3500. Fax: (847) 491-2467. E-mail: ralamb@nwu.edu. were encapsidated and expressed either by infectious
249
0042-6822/97 $25.00
Copyright q 1997 by Academic Press
All rights of reproduction in any form reserved.
AID VY 8801 / 6a4f$$$241 10-01-97 10:29:56 vira AP: VY
250 HE ET AL.
helper virus (Collins et al., 1991, 1993; De and Banerjee, and PCR (RT-PCR). Plasmids were constructed using
standard molecular biology techniques. Details of the1993; Dimock and Collins, 1993; Park et al., 1991) or
by plasmids encoding the proteins required to form a step-wise assembly of the plasmids to yield the complete
cDNA genome and nucleotide sequences of all plasmidsfunctional transcribing/replicating nucleocapsid (Baron
and Barrett, 1997; Calain et al., 1992; Calain and Roux, used are available on request from the authors. The base
plasmid for pSV5 was pUC19 and the SV5 cDNA was1993; Conzelmann and Schnell, 1994; Murphy and Parks,
1997; Pattnaik et al., 1992; Sidhu et al., 1995). The latter flanked at its left end by a T7 RNAP promoter and at the
right end by a hepatitis delta virus ribozyme (Perrottasystems used intracellular expression of N, P, and L pro-
teins under the control of a bacteriophage T7 RNA poly- and Been, 1991) followed by a T7 terminator (T7-T) (see
Fig. 1). Transcription of the cDNA by T7 RNAP producedmerase (T7 RNAP) promoter and intracellular production
of a mini replicon RNA under the control of a T7 RNAP an anti-genome (/) sense RNA transcript. It was found
helpful for purposes of plasmid stability to propagatepromoter. T7 RNAP was produced by infection of the
cells with a recombinant vaccinia virus that expressed plasmids in Escherichia coli SURE (Stratagene, La Jolla,
CA), SURE strain genotype: (e140(McrA0)D(mcrCB-T7 RNAP. Formation of the precise 3* end of the RNA
was achieved using hepatitis delta virus ribozyme (Per- hsdSMR-mrr)171 endA1 supE44 thi-1 gyrA96 relA1 lac
recB recJ sbcC umuC: :Tn5 (Kanr) uvrC [F* proABrotta and Been, 1991). These procedures were then ex-
tended to allow the rescue from cloned DNA of infectious lacqZD(M15 Tn10 (Tetr)].
rabies virus, vesicular stomatitis virus (VSV), measles
virus, Sendai virus, human parainfluenza virus type 3, Construction of an SV5 genome cDNA containing an
and rinderpest virus (Baron and Barrett, 1997; Durbin et extra gene
al., 1997; Garcin et al., 1995; Hoffman and Banerjee, 1997;
Kato et al., 1996; Lawson et al., 1995; Radecke et al., To insert an extra gene into the SV5 genome such that
it would be transcribed by the SV5 transcription complex,1995; Schnell et al., 1994; Whelan et al., 1995).
SV5 has some biological properties that make it dis- an extra copy of the semiconserved gene end (polyade-
nylation) and gene start (transcriptional start signal) se-tinct from other paramyxoviruses; e.g., (i) SV5 can repli-
cate in some cell cultures for extended periods with mini- quences (Parks et al., 1992) were inserted into the HN
3* noncoding region. Two sets of signals were used:mal cytopathic effect (Choppin, 1964), (ii) SV5 F protein,
unlike most other paramyxoviruses (reviewed in Lamb, a repetition of the proposed HN-L end/start sequences
[TTTTAAGAAAAA (intercistronic 13 nucleotides) AGG-1993), does not need its homotypic HN protein to pro-
mote fusion (Bagai and Lamb, 1995, 1996; Horvath and CCAGAAT] and the proposed NP-V/P end/start se-
quences [TTTAAAGAAAAAAA (intercistronic 1 nucleotideLamb, 1992; Horvath et al., 1992; Paterson et al., 1985,
1989), (iii) SV5 encodes an extra integral membrane pro- (T)) AGGCCCGGAC].
A synthetic oligonucleotide linker containing the newtein, SH (Hiebert et al., 1988), only found in Rubulavi-
ruses, and (iv) the SV5 V/P gene encodes the V protein, gene end/start signals and a downstream unique NotI
site to facilitate DNA manipulations was cloned into theand the P protein is encoded after the pseudo-templated
addition of nucleotides to the mRNA transcript of V HN 3* noncoding region. The cDNA encoding a mutated
form of the gene for green fluorescent protein (GFP) from(Thomas et al., 1988), and a similar situation is found
in other Rubulaviruses except Newcastle disease virus, Aequorea victoria jellyfish (pGreen Lantern-1; Gibco-BRL,
Gaithersburg, MD) was cloned into the unique NotI site.which, like the other paramyxoviruses, encodes the P
protein as the genomic version and the V protein from The construct using a duplicate of the HN/L stop/start
signals was designated pBH310-SV5 and that using thethe edited RNA (reviewed in Lamb and Kolakofsky, 1996).
Thus, production of an infectious cDNA of SV5 would NP/P stop/start signals was designated pBH311-SV5.
provide a means of investigating further aspects of bio-
logical properties of SV5. Cells and viruses
Monolayer cultures of A549, BHK-21, and MDBK andMATERIALS AND METHODS
CV-1 cells were maintained in DMEM and 10% fetal calf
Construction of a complete cDNA of the SV5 genome
serum as described previously (Paterson et al., 1984a).
Chick embryo fibroblasts (CEF) were grown as describedA complete cDNA of the 15,246-nucleotide SV5 ge-
nome was constructed from the cDNAs encoding NP previously (Lamb et al., 1976)). Modified vaccinia virus
Ankara (MVA) expressing bacteriophage T7 RNAP (Sutter(Parks et al., 1992), V/P (Thomas et al., 1988), M (Shesh-
beradaran and Lamb, 1990), F (Paterson et al., 1984a,b), et al., 1995; Wyatt et al., 1995) was grown in CEF cells
and was kindly provided by Dr. Bernard Moss (NationalHN (Hiebert et al., 1985), and L (Parks et al., 1992) and
PCR reactions to provide adaptor DNAs over some of Institutes of Health, Bethesda, MD). Plaque assays were
performed in BHK-21 or CV-1 cells as described (Pater-the intercistronic junctions. The SV5 leader and trailer
sequences were cloned by reverse transcription of vRNA son and Lamb, 1993).
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Transfection and recovery of SV5 were analyzed by SDS–PAGE using 15 or 10% polyacryl-
amide gels (Paterson and Lamb, 1993) and radioactivity
A549 cells at 95% confluency in a 3.5-cm-diameter was analyzed using a Fuji BioImager 1000 and MacBas
plate were infected with MVA at an m.o.i. of 3 in PBS software (Fuji Medical System, Stamford, CT).
containing 1% bovine serum albumin for 1 hr and then
the plasmids pSV5 and those encoding NP, P, and L Flow cytometry
[(pUC19-NP3A (Murphy and Parks, 1997), pGEM 2-P
rSV5 virus-infected CV-1 cells at 24 hr p.i. were trypsin-(Thomas et al., 1988), and pGEM 3-L (Parks et al., 1992)]
ized and chilled on ice. The cells were washed threewere transfected into cells with Lipofectin (Gibco-BRL).
times with phosphate-buffered saline deficient in calciumThe amounts of plasmids were as follows: 1 mg pSV5, 2
and magnesium and supplemented with 5% fetal calfmg pUC19 NP3A, 0.2 mg pGEM 2-P, and 2 mg pGEM 3-
serum and 0.02% sodium azide (PBS-FACS). The cellsL. After incubation for 24 hr the transfection media was
were divided into two aliquots. One aliquot was incu-changed to DMEM containing 10% fetal calf serum. After
bated with F-specific mAb F 1a (1:1000 dilution of ascites48 hr at 377, the media were harvested, cell debris pel-
fluid) (Randall et al., 1987) and the cells were washedleted by low speed centrifugation (1,250 g, 5 min), and
with PBS-FACS as described above and incubated withthe supernatant filtered through an 0.45-mM filter to re-
a goat anti-rabbit fluorescein isothiocyanate-conjugatedmove MVA. This virus stock was designated Pl and it
secondary antibody. The cells were washed a furtherwas used to generate SV5 stocks by infection of CV-
three times with PBS-FACS and fixed in 1% formaldehyde.1 cells or MDBK cells. SV5 recovered from cDNA was
GFP and F-specific fluorescence on the aliquots weredesignated rSV5.
measured on 10,000 cells using a FACSCalibur (Becton–
Dickinson, San Jose, CA) flow cytometer.Reverse transcriptase-PCR amplification
Total RNA from rSV5-infected CV-1 cells (6-cm-diame- Fluorescent microscopy
ter plates) was purified using an RNeasy kit (Qiagen,
CV-1 cells were grown on glass coverslips and in-Chatsworth, CA), according to the manufacturer’s proto-
fected with rSV5, rBH310-SV5, or rBH311-SV5. At 24 hrcol. RNAs were dissolved in 50 ml H2O and 19 ml was
p.i. cells were fixed in 2% formaldehyde and examinedused in a reverse transcriptase (RT) reaction using ap-
directly using a Nikon FXA fluorescent microscope (Ni-propriate oligonucleotide primers that annealed to the
kon Corp., Tokyo, Japan) and a FITC filter set.vRNA (0) strand. An aliquot of the cDNA was then ampli-
fied in a PCR reaction using appropriate oligonucleotide
Northern blot analysis of mRNAs
primer pairs. PCR was carried out at 947 for 1 min, 557
Poly A(/) mRNA from rSV5-infected CV-1 cells (10-cm-for 1 min, and 727 for 1 min for 40 cycles.
diameter dish) were purified and RNA analyzed on a 1.5%
Nucleotide sequencing agarose gel containing 2.2 M formaldehyde as described
previously (Paterson et al., 1984a). RNAs were trans-
Routine DNA sequencing was done using an Applied
ferred by blotting to nitrocellulose membrane and cross-
Biosystems (ABI) 310 sequencer (Applied Biosystems,
linked by u.v. irradiation and hybridized to 32P-labeled NP
Inc., Foster City, CA), according to the manufacturer’s
or GFP probes, generated using a Ready-to-Go (Phar-
protocols. For sequencing of RT-PCR products, the DNAs
macia Biotech, Piscataway, NJ) random priming kit. Blots
were electrophoresed on a 1% agarose gel and bands
were washed as described previously (Paterson et al.,
were cut out and DNA was purified using a Qiaex II kit
1984a).
(Qiagen). The purified DNA was then PCR amplified using
fluorescent dye-labeled chain terminating nucleotides
RESULTS
and the nucleotide sequence obtained using the ABI 310
Construction of cDNA to SV5 genomesequencer and ABI Prism software.
To construct a cDNA clone encoding the completeImmunoprecipitation of polypeptides
15,246 nucleotide SV5 genome, the individual cDNAs for
the NP, V/P, M, F, SH, HN, and L mRNAs were joinedCV-1 cells were infected with rSV5, rBH310-SV5,
rBH311-SV5, wt SV5 or mock-infected and at 22 hr p.i. together by using linker DNA fragments, generated by
RT-PCR on vRNA, that spanned the intercistronic junc-were labeled for 2 hr with Tran[35S] label (100 mCi/ml)
and the cells lysed in RIPA buffer and aliquots immuno- tions. Likewise, the SV5 leader and trailer RNA se-
quences were generated by RT-PCR on vRNA. The SV5precipitated using monoclonal antibody HN4b (Ng et al.,
1989), anti-F2 synthetic peptide rabbit sera (Horvath and cDNA (pSV5) was flanked on its left end by a T7 RNAP
promoter and at the right end by a hepatitis delta virusLamb, 1992), P-specific mAb 161(Thomas et al., 1988),
anti-V synthetic peptide rabbit sera (Paterson et al., 1995), ribozyme (Perrotta and Been, 1991) followed by a T7
terminator (Fig. 1). To facilitate T7 RNAP transcription 3, Gor rabbit anti-GFP (Clontech, Palo Alto, CA). Polypeptides
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FIG. 1. Schematic diagram of elements in pSV5 essential to making an antisense genome RNA and the scheme used for generating infectious SV5
from cloned cDNA. pSV5 contains a complete copy of the SV5 genome (15,246 nucleotides) and is flanked at one end by a bacteriophage T7 RNA
polymerase (T7 RNAP) promoter and at the other end by a hepatitis delta virus ribozyme and T7 transcriptional terminator (T7–T7). T7 RNA transcripts
can be synthesized under the control of the T7 promoter to yield anti-sense (/) SV5 RNA. pSV5 contains three extra G residues after the T7 RNAP
promoter and prior to the SV5 leader (Le) sequence in an attempt to increase T7 RNAP transcription efficiency. A full-length anti-genome sense SV5 RNA
transcript can be transcribed from the T7 RNAP promoter with the exact trailer sequence generated by cleavage with hepatitis delta virus ribozyme. The
filled boxes indicate the six intercistronic regions. Sequence identifying tags introduced into the genome without changing coding sequences are indicated:
(StuI), a former StuI site was mutagenized to a new HindIII site; (NcoI), a former NcoI site in the SV5 cDNA was eliminated in pSV5. The plasmids pGEM3-
L, pGEM 2-P, and pUC19 NP3A each contain the cDNA for the SV5 L, P, and NP proteins, respectively, under the control of T7 RNAP promoters such
that mRNA transcripts encoding L, P, and NP can be transcribed using T7 RNAP. A549 cells (a human cell line that is permissive for SV5 and can be
efficiently transfected) were infected with modified vaccinia virus Ankara that expresses T7 RNAP (MVA) for 1 hr and then the cells were transfected
overnight with pSV5 and the three support plasmids pGEM 3- L, pGEM 2-P, and pUC19 NP3A using lipofectin. The transfection mixture was replaced
with DMEM containing 10% fetal calf serum and the cultures were incubated for 48 hr. The culture medium was harvested and MVA removed by filtration
through a 0.45-mM filter. The supernatant was further passaged on CV-1 cells for 48 hr at which time discernable foci of syncytium formation were
observed. The virus stock was passaged once further on CV-1 cells for 48 hr.
residues were included before the SV5 leader sequence. T7 RNAP and causes low cytopathic effects and trans-
fected with pSV5 together with plasmids that expressTranscription of the cDNA by T7 RNAP produced an anti-
genome (/) sense RNA transcript. Production of a (/) SV5 NP, P, and L proteins. Expression of the NP protein
was presumed to be required to assemble the newlysense RNA was chosen because of the success in rescu-
ing infectious rabies and VSV from anti-genome tran- synthesized SV5 (/) strand RNA into nucleocapsids and
the P and L proteins to form a polymerase complex forscripts (Lawson et al., 1995; Schnell et al., 1994). In vitro
transcription of pSV5 with T7 RNAP produced an RNA synthesis of minus-strand RNA. The newly formed vRNA
sense nucleocapsids should then be equivalent to aspecies of 15,000 nucleotides and a smaller species
of10,000 nucleotides (data not shown). The minor RNA functioning nucleocapsid, competent to act as a template
species is of a size consistent with termination of tran- for replication, and begin the SV5 infectious cycle. Al-
scription at a PTH-terminator-like termination signal for though expression of the V protein was briefly considered
T7 RNAP at SV5 nucleotide 11,073 (5*-TATCTGTTT 3*) a possible requirement, as the V protein is encoded by
(Lyakhov et al., 1997). the genome RNA (Thomas et al., 1988), recent work on
replicating DI genomes with plasmid expressed proteins,
Recovery of infectious SV5 from cDNA indicated V protein expression would probably not be
required for SV5 replication (Murphy and Parks, 1997).To recover SV5 from cDNA, A549 cells were infected
with a vaccinia virus recombinant (MVA) that expresses The recovery procedure used 3.5-cm-diameter plates of
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A549 cells that were transfected for 24 hr before the protein coding) and the removal of an NcoI at nucleotide
medium was changed followed by incubation for a further 7170. To demonstrate that these sites were present in
48 hr. As has been found previously, the amount of plas- the rSV5, we reverse-transcribed vRNA from infected
mid used for expression of NP, P, and L (see Materials cells using primers that annealed close to the restriction
and Methods) as found to be important for successful sites. The RT products were then amplified by PCR using
rescue of infectious virus (Lawson et al., 1995; Murphy a second primer to generate a fragment covering the
and Parks, 1997; Pattnaik et al., 1992). The supernatant site. To ensure template RNA was present in each RT
was filtered through an 0.45-mM filter to remove vaccinia reaction, total cell RNA was run on an agarose gel and
virus and was used to infect CV-1 cells. After 48 hr incu- stained with ethidium bromide (Fig. 2A). As shown for
bation, indirect immunofluorescent staining for the SV5 the NcoI site RT/PCR (Fig. 2B) or the StuI site RT/PCR
F protein indicated many patches of fluorescence typical (Fig. 2C), an appropriately sized DNA fragment was only
of F protein expression. Although we do not know the found after a complete transfection. If the RT product
frequency at which rescue occurred, and the estimates was omitted from the reaction, or RT was omitted from
for VSV suggest it is a low frequency event (Lawson et the reaction, or the transfection lacked pGEM 3-L or
al., 1995), we obtained infectious SV5 in 10 of 10 3.5-cm- pSV5, then no proper size PCR DNA fragment was found,
diameter plates. Use of cytosine arabinoside to limit the indicating that true recovery of SV5 RNA had been
MVA replicative cycle was not found to be required. After achieved, and the data were not an artifact or contami-
a second passage of the virus on CV-1 cells, large num- nant of PCR amplification. Restriction endonuclease di-
bers of foci of SV5-induced syncytium formation were gestions were performed and the removal of the StuI
observed. and NcoI sites in the fragments was confirmed (data
not shown). Nucleotide sequencing of the purified DNA
RT-PCR amplification and identification fragments (Fig. 3) proved the loss of the StuI site and
of sequence tags loss of the NcoI site in the rSV5 as compared to the
SV5, demonstrating bona fide rescue of SV5 from cDNA.To verify the proper recovery of SV5 from cDNA, we
Analysis of the 3* end of the vRNA by RNase protectionsought the presence of two nucleotide sequences that
indicated that the 3G residues introduced to facilitate T7had been altered in the cDNA to facilitate assembly of
RNAP transcription were lost from the amplified vRNApSV5. These tags were the conversion of a StuI site at
nucleotide 4657 to a HindIII site (without altering the F (data not shown).
FIG. 2. RT-PCR amplification of RNA isolated from rSV5-infected cells. Supernatants from transfected A549 cells were filtered through a 0.45-mM
filter to remove MVA virus and passaged on CV-1 cells. At 48 hr p.i., whole cell RNA was isolated from the cells. To reverse transcribe the regions
of the SV5 genome containing the sequence tags, oligonucleotide primers which annealed to (0) sense vRNA were used, followed by PCR reactions
using oligonucleotide pairs which span the NcoI site region and the StuI site region, respectively. (A) Ethidium bromide staining of RNA used in
RT/PCR reactions. Lane 1, RNA size marker (Novagen, Inc.); lane 2, RNA from control transfected cells in which pGEM-3 L was omitted from the
transfection; lane 3, RNA from control transfected cells in which pSV5 was omitted from the transfection; lanes 4 and 5, RNA from complete
transfection of pSV5 and pGEM 3-L, pGEM 2-P, and pUC19 NP3A. (B) Ethidium bromide staining of PCR products spanning the NcoI site on the
SV5 genome. Lane 1 (lambda DNA/PstI) and lane 9 (lambda DNA/BstEII) size markers; lane 2, no DNA; lanes 3 and 4, RNA from complete transfection
but reverse transcriptase omitted from RT/PCR reaction; lane 5, RT/PCR of control transfected cells in which pGEM 3-L was omitted from the
transfection; lane 6, RT/PCR of control transfected cells in which pSV5 was omitted from the transfection; lanes 7 and 8, RT/PCR from complete
transfection. (C) Ethidium bromide staining of PCR products spanning the StuI site on the SV5 genome. Lane 8, lambda DNA PstI marker; lanes
1 –7 as lanes 2–8 in B, except that different oligonucleotide primers were used.
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FIG. 3. Nucleotide sequence of tags in SV5 recovered from cDNA. Nucleotide sequence reactions of the DNA fragments derived by RT-PCR
shown in Fig. 2. DNA products were purified and sequenced on an ABI 310 sequencer using the manufacturer’s protocols. Top row, nucleotide
sequences from nucleotides 4672–4648 and 7181–7161 of wild-type SV5 genome RNA. Bottom row, nucleotide sequences over the same regions
derived from the recovered SV5 (rSV5). Sequence of region 4672–4648 is of (/) strand and sequence of region 7181–7161 is of (0) strand.
Underlining in top row indicates restriction endonuclease sites that were changed in the pSV5 cDNA. Underlining in bottom row indicates nucleotide
changes found in rSV5.
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FIG. 4. Schematic diagram of essential elements of SV5 cDNA construct that expresses an extra gene, green fluorescent protein (GFP). 5* to the
coding region for GFP an extra copy of the gene and (GE) and gene start (GS) transcriptional signals was inserted into the HN 3* noncoding region.
In pBH310-SV5, the GE and GS sequences were those found at the HN-L intercistronic region. In pBH311-SV5, the GE and GS sequences were
those found at the NP-V/P intercistronic region. PT7  T7 RNA polymerase promoter; Le, leader sequence of SV5; Tr, trailer sequence of SV5; d
ribo, ribozyme from hepatitis delta virus; T7–T7, bacteriophage T7 RNA polymerase terminator.
Construction of an SV5 genome cDNA containing an SV5 were made to match a 6n length RNA genome
(16,056 nucleotides). The recovery of rBH310-SV5 andextra cistron encoding green fluorescent protein
rBH311-SV5 was performed as described above and the
To insert an extra gene into the SV5 genome such that
presence of the GFP cDNA in the recovered virus RNA
the SV5 polymerase complex would transcribe an extra
was demonstrated by RT/PCR using appropriate oligonu-
cistron, gene end (polyadenylation), and gene start (tran-
cleotide primers (data not shown).
scription start signal) sequences (Parks et al., 1992) were
inserted into the HN 3* noncoding region. Very little has Expression of GFP from rSV5
been determined experimentally for SV5 transcription but
we chose the site downstream of the HN coding region CV-1 cells infected with rSV5, rBH310-SV5, and rBH311-
SV5 at 24 hr p.i. were examined directly using a fluores-by analogy to a scheme used for VSV (Schnell et al.,
1996b) and we considered it likely that insertion of a new cein filter set on a microscope equipped with epifluores-
cent optics. As shown in Fig. 5, cells infected with rBH311-cistron downstream of HN would have minimal effects
on viral replication, perhaps only reducing L expression SV5 showed bright fluorescence from GFP that was dis-
persed throughout the cells, whereas rSV5-infected cellsslightly because of a polar effect on downstream tran-
scription. Two sets of signals were used, a repetition of only showed minimal autofluorescence. Cells infected
with rBH310-SV5 showed very weak fluorescence (datathe HN/L end/start sequences (pBH310-SV5) and the NP/
P end/start sequences (pBH311-SV5). We chose to intro- not shown). To quantify the GFP fluorescence and to com-
pare it to indirect fluorescent staining for the SV5 F proteinduce the cDNA encoding a mutated form of the gene
for green fluorescent protein (GFP) from the Aequorea (using an F-specific mAb and FITC-labeled goat anti-
mouse secondary antibody), aliquots of cells were ana-victoria jellyfish into the SV5 genome, as expression of
GFP might prove useful in the future to follow the spread lyzed by flow cytometry. As shown in Fig. 6, the levels of
F protein staining for cells infected with rSV5, rBH310-of virus from cell to cell. GFP cDNA (732 nucleotides)
was inserted downstream of the newly introduced tran- SV5, and rBH311-SV5 were very similar. For GFP fluores-
cence, cells infected with rBH310-SV5 gave fluorescentscriptional start signal (Fig. 4). The anticipation was that
if the stop-start signals preceding the GFP gene junction intensities only slightly over the background autofluores-
cence of rSV5-infected cells, whereas rBH311-SV5-in-sequence were functional, the HN mRNA would termi-
nate at the new poly(A) site and that GFP mRNA would fected cells yielded a strong GFP fluorescent signal. Im-
munoprecipitation of 35S-labeled polypeptides from wtinitiate at the new start site and terminate at the original
HN poly(A) site. In these constructs, care was taken over SV5, rSV5, rBH310-SV5, and rBH311-SV5-infected CV-1
cells using antisera specific for the HN, F2 , P, V, and GFPthe genome length requirement called the ‘‘rule of six.’’
For Sendai virus it was found that efficient replication proteins indicated that the expression levels of HN, F, P,
and V proteins were very similar for wt SV5 and all recov-of the genome only occurred when the total number of
nucleotides in the genome was a multiple of six (Calain ered viruses (Fig. 7). However, much less GFP was immu-
noprecipitable from rBH310-SV5-infected cells thanand Roux, 1993) and this requirement is thought to reflect
the precise nature by which nucleocapsid subunits inter- rBH311-SV5-infected cells and no GFP was immunopreci-
pitable from wt SV5- or rSV5-infected cells.act with RNA to encapsidate the RNA. The available evi-
dence suggests that SV5 has a preference but not an Analysis of the GFP mRNA that accumulated in
rBH310-SV5- and rBH311-SV5-infected CV-1 cells byabsolute requirement for a genome of 6n length (Murphy
and Parks, 1997) and hence pBH310-SV5 and pBH311- Northern blot analysis (Fig. 8), in comparison to NP
FIG. 5. Expression of GFP in CV-1 cells. Virus recovered from plasmid pBH311-SV5 and wt SV5 were used to infect CV-1 cells. At 24 hr p.i., cells
were fixed in 2% formaldehyde and examined using a fluorescein filter set on a Nikon FXA fluorescent microscope. (A) rBH311-SV5-infected cells;
(B) SV5-infected cells.
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FIG. 6. Quantification of GFP and F protein expression levels by flow cytometry. For GFP, fluorescence cells were fixed in 1% formaldehyde prior
to direct analysis using a Becton–Dickinson FACSCalibur flow cytometer. For another aliquot of cells, the cells were stained with SV5 F-specific
mAb F-1a and goat antimouse FITC-labeled IgG. 10,000 cells per sample were examined by flow cytometry. Mean fluorescence intensities for GFP
and F are indicated for the three viruses.
mRNA accumulation, indicated that (i) a GFP mRNA V/P gene end/start sequences inserted into the same
site: for rBH310-SV5 the GFP mRNA could only be ob-(800 nucleotides) could be detected and (ii) rBH310-
SV5, which contained a duplicated set of HN-L gene end/ served on prolonged exposure of the autoradiographs.
The levels of GFP mRNA accumulation for the two recov-start sequences inserted into the HN 3* untranslated
region, caused the accumulation of considerably less ered viruses mirrored the levels of GFP fluorescence and
GFP immunoprecipitable protein.GFP mRNA than rBH311-SV5, which contained the NP-
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Horvath and Lamb, 1992; Horvath et al., 1992; Paterson
et al., 1985, 1989), but for NP, V/P, and M genes the only
information we had was identity of nucleotide sequence
of different cDNAs (Parks et al., 1992; Sheshberadaran
and Lamb, 1990; Thomas et al., 1988). We were encour-
aged to proceed when we found that two independent
cDNAs of the L mRNA differed only by silent mutations,
leading us to believe we had a cDNA that could express
a functional L protein (Parks et al., 1992). Recently, Mur-
phy and Parks (1997) succeeded in replicating an SV5
DI genome using NP, P, and L expressed from these
cDNAs, indicating that the cDNAs of the SV5 polymerase
complex were functional and indicating rescue of infec-FIG. 7. Analysis of polypeptides synthesized by recovered SV5 vi-
tious virus from cDNA should be feasible.ruses. CV-1 cells were mock-infected or infected with wt SV5, rSV5,
In attempting the rescue of SV5 from cDNA we adoptedrBH310-SV5, or rBH311-SV5. At 22 hr p.i. the cells were labeled for 2
hr with Tran[35S] label (100 mCi/ml) and the cells lysed in RIPA buffer the strategy, first used by Conzelmann and coworkers
and aliquots immunoprecipitated using antisera specific for HN, F2 , (1994) for rabies virus, of expressing the anti-genome (/)
P, V, and GFP proteins. Proteins were analyzed by SDS–PAGE and RNA strand in cells. The early speculation was that if aradioactivity was analyzed by a Fuji BioImager. Lane 1, mock; lane 2,
full-length vRNA strand were synthesized in cells it wouldwt SV5; lane 3, rSV5, lane 4, rBH310-SV5; lane 5, rBH311-SV5.
anneal to mRNAs synthesized from the support plasmids
for NP, P, and L. However, recently it has been found
Stability of the GFP gene and protein expression over possible to rescue Sendai virus and HPIV-3 from cDNA
twenty passages by using the (0) vRNA strand, albeit less efficiently than
from the (/) RNA strand (Durbin et al., 1997; Kato et al.,
Examination of the insertion of an extra cistron into 1996). We found that when cells expressing T7 RNAP
VSV has shown that the extra gene is not lost and that (from infection with MVA) were transfected with the plas-
the genome is stable (Schnell et al., 1996b). We have mids that could express a full-length antigenome (/)
passaged the rBH311-SV5 virus over 20 passages in- strand SV5 RNA, and the NP, P, and L proteins, SV5 was
fecting 5 1 105 CV-1 cells at 0.01 PFU cell on each recovered 10 of 10 times on numerous occasions. We
occasion. The virus yield after 96 hr was 8 1 108 PFU/ do not know the efficiency of rescue but, nonetheless, it
cell and the fluorescent signal for GFP as measured by has the potential to be a viable system for reverse gene-
flow cytometry over 20 passages was unchanged. Thus, tics experiments.
in an 10100 expansion of the GFP-expressing rSV5, the
gene expression was maintained. The GFP RNA nucleo-
tide sequence with passaging has not been examined.
rSV5, rSV5 expressing GFP, and wt SV5 grow to the
same titer
rSV5, rBH310-SV5, rBH311-SV5, and wt SV5 were
plaque purified on CV-1 cells. Individual plaques were
picked and amplified in MDBK cells. Single-step growth
curves after infection of MDBK cells at 7 PFU/cell were
performed by harvesting virus every 6 hr. Plaques titers
of the virus on BHK-21 cells showed very similar titers
for all four viruses. The significance, if any, of the slightly
accelerated growth of SV5 at 12 hr p.i. is not know at the
present time. Nonetheless, it was observed that SV5 and
rSV5 formed slightly larger plaques than rSV5 express-
ing GFP.
DISCUSSION
FIG. 8. Northern analysis of NP and GFP mRNAs. CV-1 cells were
mock infected, infected with wt SV5, rSV5, rBH310-SV5, and rBH311-The rescue of infectious SV5 from cDNA depended on
SV5. At 20 hr p.i. poly(A)/ RNA was extracted and RNA electrophoresed
having biologically functional cDNAs of each gene. We on a 1% agarose/formaldehyde gel and transferred to nitrocellulose as
have known for many years that the cDNAs for F and described previously (Paterson et al., 1984). The filter was hybridized
with 32P-labeled probes specific for SV5 NP and GFP RNAs.HN are biologically active (Bagai and Lamb, 1995, 1996;
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FIG. 9. Single-step growth curves of wt SV5, rSV5, rBH310-SV5, and rBH311-SV5. MDBK cells were infected with the viruses at 7 PFU/cell and
the medium was harvested at 6-hr intervals. The titer of the viruses was determined by plaque assay on BHK-21 cells. The graphs shown are the
average of two sets of experiments.
It was of interest that the V protein which is encoded This was demonstrated directly by using the infectious
cDNAs of rabies virus, VSV, and respiratory syncytial (RS)by the SV5 genome (Thomas et al., 1988), with the P
mRNA resulting after the pseudo-templated transcrip- virus to express foreign genes by insertion of the foreign
gene between an extra copy of the GE/GS signals (Buk-tional addition of nucleotides (editing), was not required
to support initial SV5 replication. The SV5 V protein is reyev et al., 1996; Mebatsion et al., 1996; Schnell et al.,
1994, 1996a,b). For VSV, there is polarity of transcriptionfound associated with nucleocapsids in virions (Paterson
et al., 1995), whereas V is seemingly absent from Sendai that follows the gene order with the relative abundance
of each mRNA decreasing with distance of the gene fromvirus particles. In contrast, the Sendai virus P mRNA is
directly transcribed from the vRNA (with V protein mRNA the 3* promoter, and this attenuation is presumably as a
result of the polymerase disengaging from the template.arising through RNA editing). The Sendai virus P protein
is almost twice the size of the SV5 P protein (82 kDa Quantitation of mRNA sequence abundance at the begin-
ning and end of each gene versus across the junctionsversus 43 kDa) and thus, it had been a formal possibility
that the SV5 and Sendai P proteins would have some indicated that polymerase disengagement would occur
predominately at these boundaries (Iverson and Rose,different functional properties, but the present data now
makes this seem more unlikely. Deletion of the V protein 1981).
To use SV5 as a vector to express GFP as a foreignfrom measles virus and Sendai virus leads to normal
cellular replication of these viruses (Delenda et al., 1997; gene, we inserted two sets of GE/GS signals, those of
the NP/ V/P boundary and the HN/L boundary into theKato et al., 1997; Schneider et al., 1997), but for Sendai
virus, the V minus virus showed markedly attenuated region of the genome that is the HN mRNA 3* noncoding
region, and placed the GFP gene downstream of the newin vivo replication capacity in mice and greatly reduced
pathogenicity. Thus, although V appears to be a nones- GS signal. The total genome length was maintained as 6n
nucleotides (Calain and Roux, 1993; Murphy and Parks,sential gene in Sendai virus it appears to encode a luxury
function required for in vivo pathogenicity (Kato et al., 1997). Both recovered viruses (rBH310-SV5 and rBH311-
SV5) were viable viruses with single-step growth curves1997). It will be of great interest to determine if it is
possible to create an SV5 V minus virus. very similar to wt SV5 and expression of GFP was stable
over 20 low dilution passages (10100 fold expansion ofFor negative-strand RNA viruses with nonsegmented
genomes, the transcriptional control signals, gene end virus). It was interesting to find that the level of GFP
mRNA accumulation was much lower when transcription(GE) (polyadenylation) and gene start (GS) (transcrip-
tional initiation), were long thought to be modular units. of the cistron was under the control of the HN/L GE/GS
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mal cellular replication of Sendai virus without the trans-frame, non-signals than when the GFP transcription was under the
structural V protein. Virology 228, 55–62.control of the NP/P GE/GS sequences. The difference in
Dimock, K., and Collins, P. L. (1993). Rescue of synthetic analogs of
GFP mRNA accumulation may be due to: (a) a difference genomic RNA and replicative-intermediate RNA of human parainflu-
in mRNA stability as the mRNAs have slightly different enza virus type 3. J. Virol. 67, 2772–2778.
Durbin, A. P., Hall, S. L., Siew, J. W., Whitehead, S. S., Collins, P. L., andsequences at their immediate 5* and 3* ends due to the
Murphy, B. R. (1997). Recovery of infectious human parainfluenzadifferent GE/GS sequences, or (b) the mRNAs are equally
virus type 3 from cDNA. Virology 235, 323–332.stable and polymerase disengagement/reinitiation is a
Enami, M., Lutyjes, W., Krystal, M., and Palese, P. (1990). Introduction
function of the specific GE/GS sequences. The latter ex- of site-specific mutations into the genome of influenza virus. Proc.
planation is the one we favor and this hypothesis is ame- Natl. Acad. Sci. USA 87, 3802–3805.
Garcia-Sastre, A., and Palese, P. (1995). The cytoplasmic tail of thenable to future experimentation.
neuraminidase protein of influenza A virus does not play an importantThe data described here show it is possible to rescue
role in the packaging of this protein into viral envelopes. Virus Res.SV5 from cDNA and to use the virus as a vector to ex-
37, 37–47.
press a foreign gene. As SV5 can replicate in MDBK cells Garcin, D., Pelet, T., Calain, P., Roux, L., Curran, J., and Kolakofsky, D.
for long periods (30 –45 days) with minimal cytopathic (1995). A highly recombinogenic system for the recovery of infectious
Sendai paramyxovirus from cDNA: Generation of a novel copy-backeffect (Choppin, 1964), it may be possible to use SV5 as
nondefective interfering virus. EMBO J. 14, 6087–6094.a vector to express proteins, particularly secreted pro-
Hiebert, S. W., Paterson, R. G., and Lamb, R. A. (1985). Hemagglutinin-teins, at high yield with minimal expense.
neuraminidase protein of the paramyxovirus simian virus 5: Nucleo-
tide sequence of the mRNA predicts an N-terminal membrane an-
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